University of Illinois at Chicago
Chicago, Illinois, 60612, United States
NCT Number: NCT06758596
The purpose of this study is to better understand how people's mood, behavior, and brains respond to different recreational drugs. We are also trying to understand why some people may feel differently or their brain may respond differently than other people after taking the same recreational drug.
Trial opening soon.
Get Notified18 year–21 year
All sexes
Interventional
Early Phase 1
Chicago, Illinois, 60612, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A capsule that contains only dextrose filler administered during the first or second laboratory visit.
A capsule that contains 7.5 mg of THC as well as dextrose filler administered during the first or second laboratory visit.
Time frame: Baseline screening, baseline drug administration, and every 6 months over two years of follow-up
Participants will complete the 6-month Timeline Follow-Back (TLFB) and Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) to assess recent substance use. This measure will capture the frequency of substance use during the past 6 months, with greater values indicating more frequent substance use.
Time frame: Baseline screening and yearly over the two-year follow-up.
Participants will complete the SCID CUD diagnosis and symptom assessment at baseline screening and yearly follow-ups to evaluate the presence and severity of cannabis use disorder (CUD) and other substance use disorder (SUD) symptoms.
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration.
Participants will complete the Monetary Incentive Delay (MID) task during fMRI scanning to assess neural activation related to reward anticipation. Greater activation in reward-related brain regions (e.g., striatum, prefrontal cortex) indicates greater neural sensitivity to anticipated rewards and the impact of THC on reward processing.
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration.
Participants will complete the Bandit task during fMRI scanning. A behavioral measure of learning rate (alpha parameter) will be derived from computational models based on the Rescorla-Wagner (RW) model, with higher learning rates indicating greater learning and adaptation to reward contingencies.
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration.
Participants will complete the Bandit task during fMRI scanning, and a behavioral measure of reward sensitivity will be derived from the Rescorla-Wagner (RW) model. Greater values indicate higher sensitivity to rewards and a stronger preference for rewarding outcomes.
Time frame: First and second laboratory visits, around 90 minutes to 2 hours after drug administration.
Participants will complete the Bandit task during fMRI scanning. fMRI analysis will focus on trial-wise neural encoding of prediction errors, with greater activation indicating more salient reward learning signals in response to prediction errors, reflecting how the brain processes unexpected outcomes during reward learning.
Contact information is provided by the study sponsor or research team.
University of Illinois at Chicago
Other
Acronym: RiDE-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725289
Adolescent Substance Use, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04146714
Adolescent Behavior, Alcohol Drinking
Geneva, Switzerland
View Trial DetailsNCT07340554
Addiction, Addiction, Substance
Indianapolis, Indiana, United States
View Trial DetailsNCT04627922
Cannabis Use, Chemically-Induced Disorders
San Francisco, California, United States
View Trial Details